Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCppgroup Regulatory News (CPP)

Share Price Information for Cppgroup (CPP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 179.50
Bid: 175.00
Ask: 185.00
Change: 0.00 (0.00%)
Spread: 10.00 (5.714%)
Open: 179.50
High: 0.00
Low: 0.00
Prev. Close: 179.50
CPP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Globiva Divestment

27 Nov 2023 07:00

RNS Number : 6728U
CPPGroup Plc
27 November 2023
 

27 November 2023

CPPGroup Plc

("the Group"; or "the Company")

 

Globiva Divestment

 

CPP Group (AIM: CPP), a provider of real-time assistance products and resolution services which reduce disruptions to everyday life for millions of customers across the world, has entered into an agreement (the "Agreement") with the founders of Globiva Services Private Ltd ("Globiva") for the disposal of the Group's majority interest in Globiva for an aggregate consideration of approximately £5.1 million1 (the "Transaction"). Globiva is non-core to the Group following the announcement of its revised strategy and Change Management Programme ("CMP") in October 2022 to transform the Group to an InsurTech business, led by Blink Parametric ("Blink").

 

Background

The Group holds a 51% majority interest in Globiva, a Business Processes Management company incorporated in India, with the other 49% of the shares beneficially owned by the three founders of Globiva, Navneet Gupta, Vikram Singh Nathawat, and Ashish Goyal, who continue to manage the business (the "Globiva Founders").

 

Under amended arrangements entered into on 20 July 2022, the Globiva Founders had the option to buy back 10% of the ordinary shares in Globiva, from the Group, for a pre-agreed price of approximately £0.9 million. This was subject to Globiva meeting certain performance targets, which it is on track to achieve. However, in the normal course of business, it was further agreed that this could not be triggered until 1 January 2026 at the earliest. This Agreement supersedes the previous arrangements.

 

Transaction Rationale

· The Transaction is consistent with the Group's stated strategy to transform the Group to an InsurTech business led by Blink and supported by India and Turkey.

· The Group is currently a "trapped" investor in Globiva with limited options to realise value. In addition, the Group was likely to become a minority shareholder (January 2026) and consequently would have lost majority voting rights on key strategic decisions. The Transaction provides an exit path for the Group at an acceptable return.

· The Transaction provides cash flow, not previously forecast, over a three-year period to support the Group's CMP.

 

Transaction Structure

· The sale and transfer of ownership will be conducted over a three-year period concluding in Q1 2027.

· The total aggregate consideration of approximately £5.1 million1 (515 million Indian rupees) represents a blended 7.1x multiple on forecast EBITDA for the 2023, 2024 and 2025 calendar years. Final consideration will be based on audited EBITDA and subject to a maximum adjustment of plus or minus ten percent.

· The Group's shareholding in Globiva, currently 51%, will reduce to approximately 35% in Q1 2025; 13% in Q1 2026; and zero percent in Q1 2027.

· Cash, subject to any EBITDA performance adjustment (noted above) will be received by the Group as follows: approximately £1.2 million in 2024; £1.3 million in 2025; £1.2 million in 2026; and £1.4 million in 2027.

 

For the 2022 financial year, Globiva contributed EBITDA of £2.4 million to the Group's overall EBITDA from continuing operations of £6.9 million, albeit the Group's shareholders only ultimately benefit from 51% of Globiva's results. As at 30 June 2023, Globiva had net assets of £3.6 million.

The Transaction constitutes a related party transaction, pursuant to Rule 13 of the AIM Rules for Companies, as the Globiva Founders are Directors of Globiva. The Group's Directors consider, having consulted with the Company's nominated adviser, Liberum Capital Limited, that the terms of the Transaction are fair and reasonable insofar as the Company's shareholders are concerned.

 

Simon Pyper, Group CEO, commented:

"The agreement we have reached with Globiva is consistent with our stated strategy and provides a positive outcome for both parties. This is another forward step as we simplify the Group and transform to an InsurTech business."

 

1 Approximate, as subject to currency exchange movements.

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 as amended by The Market Abuse (Amendment) (EU Exit) Regulations 2019. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

 

Enquiries:

 

CPP Group plc

Simon Pyper, Chief Executive Officer Tel: +44 (0)7917 795601

David Bowling, Chief Financial Officer

 

 

Liberum Capital Limited

(Nominated Adviser and Sole Broker) Tel: +44 (0)20 3100 2000

Richard Lindley

Lauren Kettle

 

About CPP Group:

CPP Group is a technology-driven assistance company that creates embedded and ancillary real-time assistance products and resolution services that reduce disruption to everyday life for millions of people across the world, at the time and place they are needed, CPP Group is listed on AIM, operated by the London Stock Exchange.

 

For more information on CPP visit https://corporate.cppgroup.com/

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGRBFBLTMTTTBLJ
Date   Source Headline
17th Mar 20217:00 amRNSDirectorate Change
5th Mar 20217:00 amRNSDirectorate Change - Amendment
11th Feb 20217:00 amRNSBlock listing Interim Review
5th Feb 20218:34 amRNSDirectorate Change
18th Jan 20217:00 amRNSTrading Update
21st Dec 20205:32 pmRNSDirector/PDMR Shareholding
17th Dec 202012:26 pmRNSBlock listing Interim Review
30th Nov 20203:47 pmRNSDirectorate Change
13th Nov 20207:00 amRNSDirectorate Change
2nd Nov 202011:38 amRNSTotal Voting Rights
26th Oct 20201:30 pmRNSBlock listing Interim Review
5th Oct 202011:09 amRNSTotal Voting Rights
24th Sep 20207:00 amRNSHalf-year Report
9th Sep 202012:02 pmRNSNon Regulatory - Blink - Lloyds Lab
18th Aug 202010:19 amRNSBusiness Update
13th Aug 20207:17 amRNSBlock listing Interim Review
1st Jul 20208:29 amRNSTotal Voting Rights
30th Jun 20208:08 amRNSBlock listing Interim Review
22nd Jun 20204:08 pmRNSDirector/PDMR Shareholding
9th Jun 20209:37 amRNSDirectorate Change
28th May 202012:32 pmRNSResult of AGM
22nd May 202012:28 pmRNSTotal Voting Rights
20th May 202012:08 pmRNSSecond Price Monitoring Extn
20th May 202012:02 pmRNSPrice Monitoring Extension
19th May 202011:10 amRNSBusiness Update
1st May 20207:00 amRNSDirector/PDMR Shareholding
28th Apr 20203:42 pmRNSNotice of AGM
21st Apr 20202:48 pmRNSDirector/PDMR Shareholding
16th Apr 20207:00 amRNSFinal Results
14th Apr 20203:36 pmRNSAdditional Listing
23rd Mar 20201:17 pmRNSTrading Statement
23rd Mar 20207:00 amRNSStatement re delayed preliminary results
12th Mar 202010:13 amRNSAdditional Listing
24th Feb 202011:40 amRNSBusiness Update
11th Feb 20204:24 pmRNSBlock listing Interim Review
10th Feb 202012:43 pmRNSCPP Group India Risk award
6th Feb 20204:41 pmRNSSecond Price Monitoring Extn
6th Feb 20204:35 pmRNSPrice Monitoring Extension
3rd Feb 20201:22 pmRNSCPP advances technology offering in Turkey
20th Dec 20199:50 amRNSDirector/PDMR Shareholding
16th Dec 201912:08 pmRNSBlock listing Interim Review
12th Dec 201911:16 amRNSDirector/PDMR Shareholding
28th Nov 201911:03 amRNSBusiness Update
12th Nov 20192:40 pmRNSBusiness Update
4th Nov 20194:11 pmRNSTotal Voting Rights
21st Oct 20192:16 pmRNSBusiness update
18th Oct 201912:07 pmRNSSecond Price Monitoring Extn
18th Oct 201912:02 pmRNSPrice Monitoring Extension
1st Oct 20199:04 amRNSTotal Voting Rights
11th Sep 20198:43 amRNSBusiness Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.